President:
Professor Adam Dubin Adam Dubin is professor of biochemistry and the vice-dean at the Faculty of Biochemistry, Biophysics and Biotechnology at the Jagiellonian University. Professor Dubin is an editorial board member of Acta Biochimica Polonica, presidium member of the Committee of Biotechnology of the Polish Academy of Sciences, chairman of the interdisciplinary expert group for biotechnology at Polish Ministry of Science and High Education, presidium member of Polish Economy Chamber of Advanced Technology. He is an expert of enzymology and protein chemistry. The main research interest of professor Dublin's group focuses on structure-function relationship of enzymes and inhibitors, especially of bacterial origin, as well as the evaluation of antimicrobial peptides as possible broad-spectrum antibiotics. The characterization of staphostatin and hemocidin families is the group's significant discovery. Furthermore, Professor Dubin is the founder of a biotech company BioCentrum Ltd. Being an academic teacher and researcher and the member of the board of a BioCentrum Ltd. Professor Dubin is an example of the successful connection between science and business. He was a postdoctoral fellow at the Oklahoma Medical Research Foundation(1980) and Visiting Professor at the Department of Biochemistry, University of Georgia, Athens (1986, 1990, and 1994). Professor Jakub Golab Professor Jakub Golab graduated medicine at the Medical University of Warsaw. He was a postdoctoral fellow in Boston at the Israel Deaconess Medical Center (Harvard Institutes of Medicine) and in Dallas at the Southwestern Medical School (University of Texas). Currently he is holding a full-time professor position at the Immunology Department of the Biostructure Research Center (Medical University of Warsaw). Main research focus of prof. Gołąb lies within the area of molecular mechanisms of cancer development and novel therapy methods. Main goal of this research is to improve anticancer therapies by both decreasing side effects and increasing their efficacy.
Professor Andrzej Kolinski Professor Andrzej Kolinski is a head of Laboratory of Theory of Biopolymers research group at University of Warsaw. Professor Kolinski is a world class expert in theory of polymers, molecular modeling, bioinformatics and computational biology. His research group developed a number of innovative technologies for studing of large biomacromolecules and their assemblies. His main achivements are focused on computer modeling of proteins: structure, dynamics and thermodynamics. For many years (till 2005), he worked as a Professor in a number of leading American research institutions: Washington University, The Scripps Research Institute, Donald Danforth Plant Science Center and Center of Excellence in Bioinformatics (State University of New York). In 1995 he received International Scholar's Award of the Howard Hughes Medical Institute. Professor Kolinski is an author of nearly 200 peer-reviewed publications that received more than 4000 non-auto citations.
Professor Jan Lubinski Prof. dr hab. n. med. Jan Lubinski is one of the most famous oncologists in Poland. He is the founder and the head of International Hereditary Cancer Center in Szczecin. Prof. Lubinski's research interests are in the area of patomorphology, clinical and hereditary cancer genetics. Professor holds a PhD from the Pomeranian Medical University in Szczecin. He was a visiting scientist at Pasteur Institute in Paris, at Wistar Institute and at Jefferson Center Institute in Philadelphia. In 1996 he was promoted to Associate Professor at Pomeranian Medical University in Szczecin. In 1997 he became a member of Expert Board in Europe and Africa within the framework of "Familial Cancer and Prevention" International Union Against Cancer (UICC) programme. Prof. Lubinski is the author of around 200 papers on clinical and molecular genetics of cancers and the author and coordinator of a few EU projects ("Development of Polish Network of Hereditary Cancer Centres", "Development of Cancer Family Syndrome Registries in Eastern Europe"). J. Lubinski is the editor of a journal published under auspices of UICC - "Hereditary Cancer in Clinical Practice" and since 1998 the Polish National Consultant of Clinical Genetics. He also serves as a member of the Biotechnology Committee of Polish Academy of Sciences and Human Genetics and Molecular Pathology Committee of Polish Academy of Sciences. He was the organizer of a screening examination in the area of hereditary cancer detection for 1.5 milion population of people in Zachodniopomorskie Region of Poland. Prof. Lubinski is also the Chief Executive Officer of a Polish biotechnology company Read-Gene S.A.
Professor Ryszard Ostaszewski Ryszard Ostaszewski is an associate professor and a leader of one of the research teams at the Institute of Organic Chemistry, Polish Academy of Sciences located in Warsaw. He is also an associate professor at the interdepartmental Center for Biotechnology, Warsaw University of Technology. Previously, he was also employed at the Faculty of Chemistry, University of Technology, Warsaw. He graduated in 1984 from Faculty of Chemistry, University of Technology, Warsaw. Between years 1986-1986 he completed his PhD at the Institute of Organic Chemistry, PAS, where he also received the status of an associate professor in year 1999. He took an annual postdoctoral fellowship in professor’s D. N. Reinhoudt group, University of Twente, Holland. Professor Ostaszewski was awarded the scholarship from the Swiss Federal Institute of Technology, Zurich, Switzerland, which he conducted in the group of professor H. J. Hansen from Zurich University. His main scientific interest focuses on the elaboration of new methods for the synthesis of biologically active compounds, by means of enzymatic processes and multicomponent reactions. During his scientific career, he collaborated with numerous internal and foreign scientific teams. Between years 2002-2004 he worked with D. Portlok from Combinatorial Chemistry Section, Procter & Gamble Pharmaceuticals on the project which was fully financed by Procter & Gamble Pharmaceuticals. Lately he established the collaboration with professors Jacek Malejczyk and Jakub Gołąb, both from Warsaw Medical University. The goal is to develop small molecules with anticancer activity of potential use in oncology. This collaboration is financed by Ministry of Science and Higher Education as two independent scientific projects. Professor Ostaszewski is an author and co-author of more then 60 scientific publications and three patents.
Professor Andrzej Pilc Professor Andrzej Pilc is a Deputy Director for Scientific Research of the Institute of Pharmacology, Polish Academy of Sciences and the Head of the Department of Neurobiology in that institute. He is also a Head of the Department of Drug Economics in the Faculty of Health Sciences, Collegium Medicum of Jagiellonian University. Professor Pilc graduated from medical studies in 1972 in Faculty of Medicine of Medical University in Łódź (MD degree) and in 1977 he defended his Ph.D. thesis in the same institution. In 1982 he was awarded one year post-doctoral fellowship in Synthelabo in Paris, and in 1984 he started his 2-year stay in Medical School of Texas University in Houston. In 1987 he defended his habilitation thesis (D.Sc.) and in the same year he was promoted to the full professor. His scientific interests focus on mechanisms of action of psychotropic drugs with the special attention on anxiolytics and antidepressants. Professor Pilc was the coauthor of the hypothesis of up-regulation of GABA B receptor by the antidepressant drugs. He is currently working on the role of glutamate metabotropic receptors as targets for psychotropic drugs. Professor Pilc published nearly 200 scientific articles in international journals and is among the most cited psychopharmacologists in Poland. He is also a reviewer in a number of international journals.
Professor Jaroslaw Polanski Jaroslaw Polanski is a Professor of Chemistry at the Institute of Chemistry, University of Silesia, Katowice, Poland, where he is currently a Head of the Department of Organic Chemistry. He is graduated from the Silesian University of Technology, Gliwice, obtained his Ph.D. from the University of Silesia (1991) and D.Sc. from the Technical University of Lodz, Poland (1998). His scientific interests involve organic chemistry and chemoinformatics. He has published more than 100 peer-reviewed manuscripts, book chapters and patents in the area of drug design and discovery. Combinatorial chemistry, modeling multidimensional Quantitative Structure-Activity Relationship and practical design and synthesis of novel chemical compounds in the search for potential sweeteners, HIV-1 integrase inhibitors and antiproliferative agents are research areas particularly focused. His professional experience includes the invited short time fellowships (DAAD and Konferenz der deutschen Akademien der Wissenschaften) in Labor für Computer Chemie, Organisch-Chemisches Institut, Technische Universität München (1993) and Computer-Chemie-Centrum, Institut für Organische Chemie, Universität Erlangen-Nürnberg (1996, 1997-8), Germany and a visiting position in Laboratoire de Biotechnologies et Pharmacogenetique Appliquee, Ecole Normale Superieure de Cachan, France (2001, 2002). Professor Polanski was a Vice Dean of the Faculty of Mathematics, Physics and Chemistry (1999-2005) and a Deputy Head of the Institute of Chemistry (2005- ) of the University of Silesia. He is a member of the editorial board of Combinatorial Chemistry & High Throughput Screening.
|
